10:00-11:00 |
Opening ceremony
Convention Hall I
|
---|
10:00-10:05 |
Opening Remarks
Hee-Sug Ryu (President of KSOG, Korea) |
---|
10:05-10:10 |
Opening Remarks
Young Tae Kim (Chairperson of KSOG, Korea) |
---|
10:10-10:30 |
Certificate of Appreciation Award Ceremony Certificate of Merit Award Ceremony
Hee-Sug Ryu (President of KSOG, Korea) |
---|
10:30-10:40 |
Honorary Member Appointment Ceremony - Prof. Daisuke Aoki
Young Tae Kim (Chairperson of KSOG, Korea) |
---|
10:40-10:50 |
Obstetrics & Gynecology Science Medical Award
|
---|
10:50-11:00 |
KSOG Medical Award
|
---|
11:00-12:30 |
Plenary Session
Convention Hall I
|
---|
Chair(s) |
Hye Sung Won (University of Ulsan, Korea) Jung-Ho Shin (Korea Univ., Korea) |
---|
11:00-11:20 |
ICU Management of the OB/GYN Patient: The State of the Art in 2024
Adel Bassily-Marcus (Yale University, USA) |
---|
11:20-11:40 |
Perinatal Treatment Using Mesenchymal Stem Cells Derived from Amniotic Fluid
Mamoru Tanaka (Keio Univ., Japan) |
---|
11:40-12:00 |
Transformational Opportunities for Ovarian Cancer Patients: Today and Tomorrow
Ginger Gardner (Memorial Sloan Kettering Cancer Center, USA) |
---|
12:00-12:20 |
Transcriptomic Analysis on Endometrial Decidualization; The Gate to Understand Reproductive Failures
Joanne Kwak-Kim (Rosalind Franklin Univ., USA) |
---|
12:20-12:30 |
Discussion
|
---|
12:30-12:50 |
Luncheon Symposium¥°
Convention Hall I
|
---|
Chair(s) |
ÀÌÀç°ü (°í·ÁÀÇ´ë, Korea) |
---|
12:30-12:50 |
HPV ûÁ¤±¹À¸·ÎÀÇ µµ¾à : HPV °¡À̵å¶óÀÎ ¾÷µ¥ÀÌÆ®
ÀÓÇöÁö (Â÷ÀÇ°úÇдë, Korea) |
---|
12:50-13:10 |
Luncheon Symposium II
Convention Hall I
|
---|
Chair(s) |
Çã¼ö¿µ (°¡Å縯ÀÇ´ë, Korea) |
---|
12:50-13:10 |
ArtiSential: New Paradigm of Minimally Invasive Surgery
±è»ó¿î (¿¬¼¼ÀÇ´ë, Korea) |
---|
13:10-13:30 |
Lunch
Convention Hall I
|
---|
13:30-14:50 |
Sponsored Symposium
Convention Hall I
|
---|
Chair(s) |
ÀÌÅÂÈ (°í½ÅÀÇ´ë, Korea) |
---|
13:30-13:50 |
Fetal US screening made simple, using the Samsung Medison AI solutions
±ÇÀÚ¿µ (¿¬¼¼ÀÇ´ë, Korea) |
---|
13:50-14:10 |
Æó°æ È£¸£¸óÄ¡·á¿¡¼ È¿°ú¿Í ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏÀÌ ÀÔÁõµÈ ¸®ºñ¾Ë
À̵¿À± (¼º±Õ°üÀÇ´ë, Korea) |
---|
14:10-14:30 |
Molecular classification of endometrial cancer and its impact on treatment selection
À̸¶¸®¾Æ (¼¿ïÀÇ´ë, Korea) |
---|
14:30-14:50 |
Advancements in Topical Hemostatic Agents: Dual Mechanism and Biodegradation Properties
¾î°æÁø (¿¬¼¼ÀÇ´ë, Korea) |
---|
14:50-15:10 |
´ëÇÑ»êºÎÀΰú ÀÇÇлó ¹ßÇ¥
Convention Hall I
|
---|
14:50-15:00 |
Genome-wide polygenic risk scores for hypertensive disease during pregnancy can also predict the risk for long-term cardiovascular disease
ÀÌ½Â¹Ì (¼¿ïÀÇ´ë, Korea) |
---|
15:00-15:10 |
Serial Circulating Tumor DNA Analysis with a Tumor Naive Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer
±èÀ¯³ª (¿¬¼¼ÀÇ´ë, Korea) |
---|
15:10-16:00 |
Featured oral presentation [GO]
Convention Hall I
|
---|
Chair(s) |
±èÅÂÁø (°Ç±¹ÀÇ´ë, Korea) |
---|
15:10-15:20GO11 |
Artificial Intelligence in Ovarian Cancer Detection: A Comprehensive Analysis of Multi-Institutional Imaging Data
¹ÚÁ¾Âù (¾ÆÁÖÀÇ´ë, Korea) |
---|
15:20-15:30GO12 |
Artificial Intelligence in Ovarian Cancer Detection: A Comprehensive Analysis of Multi-Institutional Imaging Data
À¯Áö±Ù (°¡Å縯ÀÇ´ë, Korea) |
---|
15:30-15:40GO13 |
Predictive Value of MRI Findings for Treatment Outcomes in Early Endometrial Cancer Patients Undergoing Fertility-Sparing Treatment
¹Ú¿ëÈñ (°Ç±¹ÀÇ´ë, Korea) |
---|
15:40-15:50GO15 |
Comparison of Outcome between MIS versus Open Surgery and Identifying Risk factors for Additional Analgesic Use in Overweight or Obese patients with Stage I Borderline Ovarian Tumor
À̼±¹Ì (°í·ÁÀÇ´ë, Korea) |
---|
16:00-16:50 |
Featured oral presentation [GO]
Convention Hall I
|
---|
Chair(s) |
¼º¼®ÁÖ (Â÷ÀÇ°úÇдë, Korea) |
---|
16:00-16:10GO15 |
Comparison of Outcome between MIS versus Open Surgery and Identifying Risk factors for Additional Analgesic Use in Overweight or Obese patients with Stage I Borderline Ovarian Tumor
À̼±¹Ì (°í·ÁÀÇ´ë, Korea) |
---|
16:10-16:20GO16 |
Association between Peritoneal Washing Cytology-Derived Immune Cells and Immunohistochemical Markers in Endometrial Cancer
ÀÌ½Â¹Ì (°è¸íÀÇ´ë, Korea) |
---|
16:20-16:30GO17 |
The Efficacy of Photodynamic Therapy with photosensitizer Chlorin e6 in the Treatment of Endometrial Cancer
ÇÑ»óÇå (Â÷ÀÇ°úÇдë, Korea) |
---|
16:30-16:40GO18 |
Factors Influencing Recurrence-Free Outcomes in Patients With Positive Margins After Loop Electrosurgical Excisional Procedure Conization
ȲÀμ± (°¡Å縯ÀÇ´ë, Korea) |
---|
16:40-16:50GO19 |
Impact of ARID1A and PPP2R1A Mutations on the Efficacy of Gemcitabine and Immune Checkpoint Inhibitors in Recurrent Ovarian Clear Cell Carcinoma: A Retrospective Analysis
³ëÁØÈ£ (¼¿ïÀÇ´ë, Korea) |
---|
16:50-17:40 |
Featured oral presentation [OB]
Convention Hall I
|
---|
Chair(s) |
ÃÖ¼ºÁø (¿¬¼¼¿øÁÖÀÇ´ë, Korea) |
---|
16:50-17:00OB10 |
Adverse Pregnancy Outcomes Linked to Increased Risk of Diabetes: A Long-term Study
±èÁöȸ (ÀÌÈÀÇ´ë, Korea) |
---|
17:00-17:10OB11 |
Comparison of Neonatal Outcome for COVID-19 Vaccination in Korean Pregnant Women: Nationwide population-based cohort study
À̼¼Áø (°¿øÀÇ´ë, Korea) |
---|
17:10-17:20OB12 |
Polycystic ovarian syndrome as an independent risk factor for gestational diabetes and preterm birth
±èÀÇÇõ (Â÷ÀÇ°úÇдë, Korea) |
---|
17:20-17:30OB13 |
Analysis of cell-free DNA test in maternal blood in screening for trisomies: consequences of a no call result
±èÀÇÇõ (Â÷ÀÇ°úÇдë, Korea) |
---|
17:30-17:40OB14 |
A Study on Developing a Community-Based Forest Therapy Program Model Integrating Healthcare for Vulnerable Pregnant Women
ÀÌ°æÁÖ (±¹¸³ÀçÈ°¿ø, Korea) |
---|